1.National Nosocomial Infections Surveillance (NNIS). System report, data summary from January 1992 to June 2002, issued August 2002. American Journal of Infection Control 2002; 30: 458–475.
2.Barrett FF, McGehee RF Jr., Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. New England Journal of Medicine 1968; 279: 441–448.
3.CDC. Methicillin-resistant Staphylococcus aureus infections in correctional facilities – Georgia, California, and Texas, 2001–2003. Morbidity and Mortality Weekly Report 2003; 52: 992–996.
4.CDC. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants – Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000–2003. Morbidity and Mortality Weekly Report 2003; 52: 793–795.
5.CDC. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections – Los Angeles County, California, 2002–2003. Morbidity and Mortality Weekly Report 2003; 52: 88.
6.Diekema DJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clinical Infectious Diseases 2001; 32 (Suppl. 2): S114–S132.
7.Fichtenbaum CJ, Dunagan WC, Powderly WG. Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. Journal of the Acquired Immune Deficiency Syndrome and Human Retrovirology 1995; 8: 51–57.
8.Northfelt DW, Polsky B. Bacteremia in persons with HIV infection. AIDS Clinical Reviews 1991; 1: 59–79.
9.Senthilkumar A, Kumar S, Sheagren JN. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clinical Infectious Diseases 2001; 33: 1412–1416.
10.Alonso R, et al. Outbreak among HIV-infected patients of Staphylococcus aureus resistant to cotrimoxazole and methicillin. Infection Control and Hospital Epidemiology 1997; 18: 617–621.
11.Anderson EJ, et al. A series of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in HIV-infected patients. Journal of Acquired Immune Deficiency Syndrome 2006; 41: 125–127.
12.Bar A, et al. Spectrum of bacterial isolates in HIV-positive patients with skin and soft tissue infections: emergence of methicillin-resistant Staphylococci. AIDS 2003; 17: 1253–1256.
13.Eulalia VM, et al. Nosocomial infection with methicillin resistant Staphylococcus aureus in 14 human immunodeficiency virus infected patients. Medicina Clínica (Barcelona) 1997; 109: 261–263.
14.Gordon RJ, et al. A molecular epidemiological analysis of 2 Staphylococcus aureus clonal types colonizing and infecting patients with AIDS. Clinical Infectious Diseases 2005; 40: 1028–1036.
15.Klein PA, et al. Prevalence of methicillin-resistant Staphylococcus aureus in outpatients with psoriasis, atopic dermatitis, or HIV infection. Archives of Dermatology 1997; 133: 1463–1465.
16.Lee NE, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clinical Infectious Diseases 2005; 40: 1529–1534.
17.Mathews WC, et al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. Journal of Acquired Immune Deficiency Syndrome 2005; 40: 155–160.
18.McDonald LC, et al. Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus. International Journal of STD & AIDS 2003; 14: 473–477.
19.Shet A, et al. Colonization and subsequent skin and soft tissue infection due to methicillin-resistant Staphylococcus aureus in a cohort of otherwise healthy adults infected with HIV type 1. Journal of Infectious Diseases 2009; 200: 88–93.
20.Sztramko R, et al. Community-associated methicillin-resistant Staphylococcus aureus infections in men who have sex with men: a case series. Canadian Journal of Infectious Disease and Medical Microbiology 2007; 18: 257–261.
21.Skiest DJ, et al. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. Journal of Infection 2007; 54: 427–434.
22.Skiest D, et al. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Medicine 2006; 7: 361–368.
23.Klevens RM, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association 2007; 298: 1763–1771.
24.Popovich KJ, et al. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clinical Infectious Diseases 2010; 50: 979–987.
25.Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. American Journal of Public Health 1992; 82: 703–710.
26.Rosario-Rosado RV, Rene AA, Jones B. Descriptive analysis of patients with community-onset and hospital-onset methicillin-resistant Staphylococcus aureus infections. Infection Control and Hospital Epidemiology 2004; 25: 171–173.
27.Kempker RR, et al. Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremia. Journal of Infection 2010; 61: 372–381.
28.Davis SL, et al. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology 2006; 27: 1025–1031.
29.Teutsch SM, Churchill RE. Principles and Practice of Public Health Surveillance, 2nd edn.Oxford University Press, 2000.
30.Kallen AJ, et al. Health care-associated invasive MRSA infections, 2005–2008. Journal of the American Medical Association 2010; 304: 641–648.
31.Kupfer M, et al. MRSA in a large German University Hospital: male gender is a significant risk factor for MRSA acquisition. GMS Krankenhaushygiene Interdisziplinär 2010; 5: 1–8.
32.King MD, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Annals of Internal Medicine 2006; 144: 309–317.
33.Padoveze MC, et al. Nasal MRSA colonization of AIDS Patients cared for in a Brazilian university hospital. Infection Control and Hospital Epidemiology 2001; 22: 783–785.
34.Peters PJ, et al. Methicillin-resistant Staphylococcus aureus colonization in HIV-infected outpatients is common and detection is enhanced by groin culture. Epidemiology and Infection 2011; 139: 998–1008.
35.Crum-Cianflone NF, et al. Association of methicillin-resistant Staphylococcus aureus (MRSA) colonization with high-risk sexual behaviors in persons infected with Human Immunodeficiency Virus (HIV). Medicine (Baltimore) 2011; 90: 379–389.
36.Chacko J, Kuruvila M, Bhat GK. Factors affecting the nasal carriage of methicillin-resistant Staphylococcus aureus in human immunodeficiency virus-infected patients. Indian Journal of Medical Microbiology 2009; 27: 146–148.
37.Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clinical Microbiology Reviews 1997; 10: 505–520.
38.Crum-Cianflone NF, Burgi AA, Hale BR. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. International Journal of STD & AIDS 2007; 18: 521–526.
39.Liu C, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004–2005. Clinical Infectious Diseases 2008; 46: 1637–1646.
41.Herwaldt LA. Control of methicillin-resistant Staphylococcus aureus in the hospital setting. American Journal of Medicine 1999; 106 (Suppl. 1): S8–S11.